MyHealthChecked PLC
("MyHealthChecked" or the "Company")
Notice of Results
MyHealthChecked PLC (AIM: MHC), the consumer home-testing healthcare company, will announce its final results for the year ended 31 December 2023 on Tuesday 4 June 2024.
Investor presentation
Penny McCormick, Chief Executive Officer, Lesley Innes, Chief Finance Officer, and Adam Reynolds, Non-executive Chairman will provide a live presentation relating to the final results via the Investor Meet Company platform on Tuesday 4 June 2024 at 16:00 BST.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 9:00am BST the day before the meeting or at any time during the live presentation. Investors can sign up to Investor Meet Company for free and add to meet MyHealthChecked PLC via:
https://www.investormeetcompany.com/myhealthchecked-plc/register-investor
Investors who already follow MyHealthChecked Plc on the Investor Meet Company platform will automatically be invited.
For further information contact:
| MyHealthChecked plc | |||
| Penny McCormick, Chief Executive Officer | via Walbrook PR | ||
| | | ||
| SPARK Advisory Partners Limited (NOMAD) | Tel: +44 (0)20 3368 3550 | ||
| Neil Baldwin / Jade Bayat | | ||
| | | ||
| Dowgate Capital Limited (Broker) | Tel: +44 (0)20 3903 7715 | ||
| David Poutney / Nicholas Chambers | | ||
| | | ||
| Walbrook PR Ltd (Media & IR) | Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com | ||
| Paul McManus / Alice Woodings | Mob: +44 (0)7980 541 893 / +44(0)7407 804 654 | ||
About MyHealthChecked PLC (www.myhealthcheckedplc.com)
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home rapid tests, as well as DNA, RNA and blood sample collection kits which have been created to support customers on their journeys to wellness. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analysed in partner laboratories for a range of biomarkers. The tests have been made available online and for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.